These results suggest that central AT1R blockade would attenuate the excess blood pressure elevation in early active phase and continuous blood pressure elevation during rest phase independent of depressor response in hypertension and that these benefits of central AT1R blockade on dairy blood pressure variability might be due to sympathoinhibition with baroreflex improvement. The gene discussed is AGTR1; the disease is hypertensive disorder.